<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000683641">
  <TermName>ABVE-PC regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC, DBVE-PC, and DBVE-PC regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000728063" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ABVE-PC regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000728064" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen ABVE-PC&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen ABVE-PC</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa con radioterapia para el tratamiento del linfoma de Hodgkin infantil. Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de vincristina, etopósido, prednisona y ciclofosfamida. También se llama ABVE-PC, DBVE-PC y régimen DBVE-PC.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-09-24</DateFirstPublished>
  <DateLastModified>2010-09-29</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000683513" url="/about-cancer/treatment/drugs/ABVE-PC">ABVE-PC</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
